Ostchega Y - Search Results

1

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC. Ozols RF, et al. Among authors: ostchega y. J Clin Oncol. 1988 Jun;6(6):1031-40. doi: 10.1200/JCO.1988.6.6.1031. J Clin Oncol. 1988. PMID: 2453619 Clinical Trial.

2

High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer.

Rothenberg ML, Ostchega Y, Steinberg SM, Young RC, Hummel S, Ozols RF. Rothenberg ML, et al. Among authors: ostchega y. J Natl Cancer Inst. 1988 Nov 16;80(18):1488-92. doi: 10.1093/jnci/80.18.1488. J Natl Cancer Inst. 1988. PMID: 2846858

3

High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

Ozols RF, Ostchega Y, Myers CE, Young RC. Ozols RF, et al. Among authors: ostchega y. J Clin Oncol. 1985 Sep;3(9):1246-50. doi: 10.1200/JCO.1985.3.9.1246. J Clin Oncol. 1985. PMID: 2993535

4

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.

Louie KG, Ozols RF, Myers CE, Ostchega Y, Jenkins J, Howser D, Young RC. Louie KG, et al. Among authors: ostchega y. J Clin Oncol. 1986 Nov;4(11):1579-85. doi: 10.1200/JCO.1986.4.11.1579. J Clin Oncol. 1986. PMID: 3095501 Clinical Trial.

5

High-dose carboplatin in refractory ovarian cancer patients.

Ozols RF, Ostchega Y, Curt G, Young RC. Ozols RF, et al. Among authors: ostchega y. J Clin Oncol. 1987 Feb;5(2):197-201. doi: 10.1200/JCO.1987.5.2.197. J Clin Oncol. 1987. PMID: 3543243

6

Retinal toxicity after high-dose cisplatin therapy.

Wilding G, Caruso R, Lawrence TS, Ostchega Y, Ballintine EJ, Young RC, Ozols RF. Wilding G, et al. Among authors: ostchega y. J Clin Oncol. 1985 Dec;3(12):1683-9. doi: 10.1200/JCO.1985.3.12.1683. J Clin Oncol. 1985. PMID: 4067616

7

Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients.

Reed E, Ostchega Y, Steinberg SM, Yuspa SH, Young RC, Ozols RF, Poirier MC. Reed E, et al. Among authors: ostchega y. Cancer Res. 1990 Apr 15;50(8):2256-60. Cancer Res. 1990. PMID: 2180564

8

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Ozols RF, Cunnion RE, Klecker RW Jr, Hamilton TC, Ostchega Y, Parrillo JE, Young RC. Ozols RF, et al. Among authors: ostchega y. J Clin Oncol. 1987 Apr;5(4):641-7. doi: 10.1200/JCO.1987.5.4.641. J Clin Oncol. 1987. PMID: 3559654

9

High dose cisplatin and high dose carboplatin in refractory ovarian cancer.

Ozols RF, Behrens BC, Ostchega Y, Young RC. Ozols RF, et al. Among authors: ostchega y. Cancer Treat Rev. 1985 Sep;12 Suppl A:59-65. doi: 10.1016/0305-7372(85)90019-2. Cancer Treat Rev. 1985. PMID: 3910223

10

High-dose cisplatin in hypertonic saline.

Ozols RF, Corden BJ, Jacob J, Wesley MN, Ostchega Y, Young RC. Ozols RF, et al. Among authors: ostchega y. Ann Intern Med. 1984 Jan;100(1):19-24. doi: 10.7326/0003-4819-100-1-19. Ann Intern Med. 1984. PMID: 6197916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters